# Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma

> **NCT00002634** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 45 (estimated)

## Conditions studied

- Neuroblastoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** monoclonal antibody 3F8
- **DRUG:** cisplatin
- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **DRUG:** mesna
- **DRUG:** perfosfamide
- **DRUG:** vincristine sulfate
- **PROCEDURE:** autologous bone marrow transplantation
- **PROCEDURE:** in vitro-treated bone marrow transplantation
- **RADIATION:** low-LET cobalt-60 gamma ray therapy
- **RADIATION:** low-LET photon therapy
- **RADIATION:** radioisotope therapy

## Key facts

- **NCT ID:** NCT00002634
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-02
- **Primary completion:** 2004-09
- **Final completion:** 2004-09
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2013-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002634, "Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00002634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*